Skip to content

Company information lookup

SCIGEN LIMITED (SIE)

Involved in the development, marketing and sales of a portfolio of bio-pharmaceutical products. These products include vaccines, which are designed to prevent disease and therapeutic bio-pharmaceuticals, which are intended to cure, suppress or minimize disease progression.

On this page you will find:

Company snapshot
Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products
ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
SIE 0.020 -20% 0.017 0.025 0.020 0.020 0.020 26,800

SCIGEN LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code SIE
Securities
Official Listing Date 15 November, 2002
GICS Industry Group Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign? No
Internet Address http://www.scigenltd.com
Registered Office Address Suite 1, 13B Narabang Way, BELROSE, NSW, AUSTRALIA, 2085
Head Office Telephone 02-9485-1800
Head Office Fax 02-9485-1888
Share Registry COMPUTERSHARE INVESTOR SERVICES PTY LIMITED
LEVEL 5, 115 GRENFELL STREET, ADELAIDE, SA, AUSTRALIA, 5000
Share Registry Telephone 1300 787 272
Directors / Senior Management
Mr Slawomir Ziegert (Executive Chairman, CEO, Executive Director)
Ms Jenny Low (Executive Director, Administrator)
Mr Adam Polonek (Executive Director, CFO)
Mr Marcin Dukaczewski (Non Exec. Director)
Mr Kenneth Gross (Non Exec. Director)
Mr Mateusz Kosecki (Non Exec. Director)
Mr Amol Shah (Non Exec. Director)
Mrs Joanna Szymanska-Bulska (Non Exec. Director)
Mr Adam Wilczega (Non Exec. Director)
Company Secretary Ms Jenny Low
Principal Activities Involved in the development, marketing and sales of a portfolio of bio-pharmaceutical products. These products include vaccines, which are designed to prevent disease and therapeutic bio-pharmaceuticals, which are intended to cure, suppress or minimize disease progression.

SCIGEN LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
31/03/2014   Full Year Statutory Accounts 101 PDF
28/02/2014 asterix Preliminary Final Report 24 PDF
28/01/2014 asterix Appendix 4C - quarterly 5 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
07 Apr 2014 0.025 0% 0.025 0.025 1,200
04 Apr 2014 0.025 0% 0.025 0.025 19,380
01 Apr 2014 0.025 0% 0.025 0.025 10
26 Mar 2014 0.025 -16.67% 0.025 0.025 610
14 Feb 2014 0.030 0% 0.030 0.030 30,000

* Volume of shares shown represents only those shares traded on ASX.

SCIGEN LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security SIE. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security SIE

Warrants & Structured Products

No warrants & Structured Products are available over the security SIE

ASX CFDs

No Contracts For Differences are available over the security SIE